Stem cell therapy for central nervous system demyelinating disease

被引：14
|
作者：
Manganas L.N. [1 ]
Maletic-Savatic M. [1 ]
机构：
[1] Department of Neurology, Stony Brook University, Stony Brook
来源：
Current Neurology and Neuroscience Reports | 2005年 / 5卷 / 3期
关键词：
Multiple Sclerosis; Experimental Autoimmune Encephalomyelitis; Neural Stem Cell; Stem Cell Therapy; Bone Marrow Stem Cell;
D O I：
10.1007/s11910-005-0050-z
中图分类号：
学科分类号：
摘要：
Recent advances in cell-based therapies for demyelinating central nervous system diseases have demonstrated the ability to restore damaged neuronal architecture and function. Demyelinated axons in patients with multiple sclerosis can spontaneously remyelinate over time; however, the rate and extent at which remyelination occurs is inadequate for complete recovery. Previous attempts aimed at regenerating myelin-forming cells have been successful but limited by the multifocal nature of the lesions and the inability to produce large numbers of myelin-producing cells in culture. Stem cell-based therapy can overcome these limitations to some extent and may prove useful in the future treatment of demyelinating diseases. Copyright © 2005 by Current Science Inc.
引用
收藏
页码：225 / 231
页数：6
相关论文
共 50 条
  • [21] Acute Demyelinating Disorders of the Central Nervous System
    Harris, Meghan K.
    Maghzi, Amir Hadi
    Etemadifar, Masoud
    Kelley, Roger E.
    Gonzalez-Toledo, Eduardo
    Minagar, Alireza
    CURRENT TREATMENT OPTIONS IN NEUROLOGY, 2009, 11 (01) : 55 - 63
  • [22] The therapeutic use of gene therapy in inflammatory demyelinating diseases of the central nervous system
    Furlan, R
    Pluchino, S
    Martino, G
    CURRENT OPINION IN NEUROLOGY, 2003, 16 (03) : 385 - 392
  • [23] Demyelinating and thrombotic disease of the central nervous system: common pathogenic and triggering factors
    Koudriavtseva, Tatiana
    Renna, Rosaria
    Plantone, Domenico
    Mainero, Caterina
    FRONTIERS IN NEUROLOGY, 2015, 6
  • [24] Central Nervous System Demyelinating Disease Protection by the Human Commensal Bacteroides fragilis Depends on Polysaccharide A Expression
    Ochoa-Reparaz, Javier
    Mielcarz, Daniel W.
    Ditrio, Lauren E.
    Burroughs, Ashley R.
    Begum-Haque, Sakhina
    Dasgupta, Suryasarathi
    Kasper, Dennis L.
    Kasper, Lloyd H.
    JOURNAL OF IMMUNOLOGY, 2010, 185 (07) : 4101 - 4108
  • [25] Vitamin D Supplementation in Central Nervous System Demyelinating DiseaseEnough Is Enough
    Haeusler, Darius
    Weber, Martin S.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (01)
  • [26] Central nervous system demyelinating diseases: glial cells at the hub of pathology
    Costa, Vinicius Gabriel Coutinho
    Araujo, Sheila Espirito-Santo
    Alves-Leon, Soniza Vieira
    Gomes, Flavia Carvalho Alcantara
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [27] Immunotherapy of inflammatory demyelinating diseases of the central nervous system
    Johu J. Bright
    Subramaniam Sriram
    Immunologic Research, 2001, 23 : 245 - 252
  • [28] Olfactory Pathology in Central Nervous System Demyelinating Diseases
    DeLuca, Gabriele C.
    Joseph, Albert
    George, Jithin
    Yates, Richard L.
    Hamard, Marie
    Hofer, Monika
    Esiri, Margaret M.
    BRAIN PATHOLOGY, 2015, 25 (05) : 543 - 551
  • [29] Imaging evaluation of demyelinating processes of the central nervous system
    Smith, Alice Boyd
    Smirniotopoulos, James G.
    POSTGRADUATE MEDICAL JOURNAL, 2010, 86 (1014) : 218 - 229
  • [30] Central nervous system inflammatory demyelinating disorders of childhood
    Kamate, Mahesh
    Chetal, Vivek
    Tonape, Venkatesh
    Mahantshetti, Niranjana
    Hattiholi, Virupaxi
    ANNALS OF INDIAN ACADEMY OF NEUROLOGY, 2010, 13 (04) : 289 - 292
12345